World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
72
Citations
19573
World Ranking
2208
National Ranking
1069

Medicine

D-Index
72
Citations
19739
World Ranking
19820
National Ranking
9873

Bruce L. Zuraw publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Bruce L. Zuraw sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 282 publications — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Bruce L. Zuraw D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Bruce L. Zuraw sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 72 D-Index — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Bruce L. Zuraw is affiliated with the University of California, San Diego in the United States. Their research is primarily situated within the field of Medicine, with significant focus on Genetics, Hematology, Pathology and Forensic Medicine, Immunology, and Molecular Biology.

Their main research topics include coagulation, bradykinin, polyphosphates, and angioedema. Additional areas of focus involve hemophilia treatment and research, autoimmune bullous skin diseases, mast cells and histamine, urticaria and related conditions, enzyme function and inhibition, and vitamin K research studies.

Zuraw has contributed extensively to several publication venues, including:

  • Journal of Allergy and Clinical Immunology
  • Annals of Allergy Asthma & Immunology
  • Allergy and Asthma Proceedings
  • The Journal of Allergy and Clinical Immunology In Practice
  • PubMed

They have collaborated frequently with researchers such as Sandra C. Christiansen, Marc A. Riedl, William R. Lumry, Timothy Craig, and Aleena Banerji.

Among recent papers authored or coauthored by Bruce L. Zuraw are:

  • "Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial," 2020, Journal of Allergy and Clinical Immunology
  • "The international WAO/EAACI guideline for the management of hereditary angioedema-The 2021 revision and update," 2022, Allergy
  • "US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema," 2020, The Journal of Allergy and Clinical Immunology In Practice
  • "The international WAO/EAACI guideline for the management of hereditary angioedema - The 2021 revision and update," 2022, World Allergy Organization Journal
  • "Randomized Trial of the Efficacy and Safety of Berotralstat (BCX7353) as an Oral Prophylactic Therapy for Hereditary Angioedema: Results of APeX-2 Through 48 Weeks (Part 2)," 2021, The Journal of Allergy and Clinical Immunology In Practice

Best Publications

  • International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences

    L. M. Fredrik Leeb-Lundberg;Francois Marceau;Werner Müller-Esterl;Douglas J. Pettibone

  • Clinical practice. Hereditary angioedema.

    Bruce L Zuraw

  • The diagnosis and management of acute and chronic urticaria: 2014 update.

    Jonathan A. Bernstein;David M. Lang;David A. Khan;Timothy Craig

  • Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group

    Marco Cicardi;W. Aberer;A. Banerji;M. Bas

  • Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis.

    P A Guerne;B L Zuraw;J H Vaughan;D A Carson

  • 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema

    Tom Bowen;Marco Cicardi;Henriette Farkas;Konrad Bork

  • The international WAO/EAACI guideline for the management of hereditary angioedema—The 2017 revision and update

    M. Maurer;M. Magerl;I. Ansotegui;E. Aygören-Pürsün

  • WAO Guideline for the Management of Hereditary Angioedema

    Timothy Craig;Emel A.ygören Pürsün;Konrad Bork;Tom Bowen

  • Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary Angioedema

    Bruce L. Zuraw;Bruce L. Zuraw;Paula J. Busse;Martha White;Joshua Jacobs

  • The international WAO/EAACI guideline for the management of hereditary angioedema – the 2017 revision and update

    Marcus Maurer;Markus Magerl;Ignacio Ansotegui;Emel Aygören-Pürsün

  • Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: Consensus report of an International Working Group

    M. Cicardi;K. Bork;T. Caballero;T. Craig

  • US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema.

    Paula J. Busse;Sandra C. Christiansen;Marc A. Riedl;Aleena Banerji

  • Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical Trial

    Aleena Banerji;Marc A. Riedl;Jonathan A. Bernstein;Marco Cicardi

  • Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema

    Bruce Zuraw;Marco Cicardi;Robyn J. Levy;Jan H. Nuijens

  • Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema

    Tom Bowen;Marco Cicardi;Konrad Bork;Bruce Zuraw

  • TGF-β1 induced epithelial to mesenchymal transition (EMT) in human bronchial epithelial cells is enhanced by IL-1β but not abrogated by corticosteroids

    Astrid M Doerner;Bruce L Zuraw

  • Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor

    Hilary Longhurst;Marco Cicardi;Timothy Craig;Konrad Bork

  • Rapid plunger immunoassay method and apparatus

    Joseph W. Bohn;Peter A. Cohen;Bruce L. Zuraw

  • The anti-inflammatory effect of glucocorticoids is mediated by glucocorticoid-induced leucine zipper in epithelial cells

    Jane Eddleston;Jack Herschbach;Amy L. Wagelie-Steffen;Sandra C. Christiansen;Sandra C. Christiansen

  • Inflammatory microcrystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes

    Pierre‐André Guerne;Robert Terkeltaub;Bruce Zuraw;Martin Lotz

  • Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel.

    Bruce L Zuraw;Konrad Bork;Karen E Binkley;Aleena Banerji

Frequent Co-Authors

Timothy J. Craig
Timothy J. Craig Pennsylvania State University
Jonathan A. Bernstein
Jonathan A. Bernstein University of Cincinnati Medical Center
Marco Cicardi
Marco Cicardi University of Milan
Hilary Longhurst
Hilary Longhurst Auckland District Health Board
Joshua J. Jacobs
Joshua J. Jacobs Rush University Medical Center
Marcus Maurer
Marcus Maurer Charité - University Medicine Berlin
Martin Lotz
Martin Lotz Scripps Research Institute
Michael M. Frank
Michael M. Frank Duke University
Jacques Hébert
Jacques Hébert Université Laval
James A. Koziol
James A. Koziol Scripps Research Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in immunology often intersects with various healthcare roles that support research, clinical trials, or patient care. Many students explore options such as nursing degrees, which provide a solid foundation in biology and patient interaction. For those without a nursing background, online BSN programs for non nurses offer accessible pathways to enter the nursing field and complement immunology expertise.

If time is a factor, accelerated nursing programs can be a strategic choice. These fast-track options allow students to complete their degrees quicker while maintaining rigorous clinical education, helping them quickly transition into healthcare roles relevant to immunologic research or treatment.

For those interested in practical nursing roles, fastest and easiest LPN programs provide a manageable entry point into the nursing profession. Licensed Practical Nurses often work closely with immunologists in clinical contexts, making this a valuable stepping stone career-wise.

Advanced practice roles like nurse practitioners are also increasingly popular. Exploring the easiest nurse practitioner program options can help prospective students find the best fit for graduate-level training that complements an immunology background and enhances clinical expertise.

Best Scientists Citing Bruce L. Zuraw

Trending Scientists

Recently Published Articles